Table.

Frequency and percentage of final treatment outcome (enrolled set).

Final treatment outcome	Delamanid (n = 86)
	n (%)	95% CI*
Cured†	49 (57.0)	46.5–67.4
Treatment completed‡	17 (19.8)	11.4–28.2
Lost to follow-up	11 (12.8)	5.7–19.8
Treatment failed§	1 (1.2)	0–6.31
Death	3 (3.5)	0–7.4
Not evaluated¶	5 (5.8)	1.9–13.0

^*The 95% confidence interval is based on a binomial distribution (for example cured vs. not cured) using the PROC FREQ procedure (SAS Institute, Cary, NC, USA).

^†Patients who completed the treatment as recommended by the national policy without evidence of failure and three or more consecutive cultures taken at least 30 days apart were negative after the intense phase.

^‡Patients who completed the treatment as recommended by the national policy without evidence of failure, but no record that three or more consecutive cultures taken at least 30 days apart were negative after the intensive phase.

^§Patient for whom treatment was terminated or there was a need for permanent regimen change of at least two anti-TB drugs.

^¶A patient for whom no treatment outcome was assigned (e.g., transferred out cases). CI = confidence interval.